Delivery Order SPE2DB20D3101-SPE2DB25FRSL0
- Not listed
- The Defense Logistics Agency awarded a $15,808.62 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. The contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and carries firm fixed pricing under a non-set-aside competitive award. Performance of the contract is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $15,235.54 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. This firm fixed-price delivery order, awarded on July 28, 2025, with a completion date of July 29, 2025, represents a non-competitive, non-set-aside procurement executed against an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $10.7K firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely-used anticoagulant medication. The contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a non-set-aside, competitively awarded transaction. Performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $19,111.33 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This contract, executed on July 29, 2025, with an ultimate completion date of July 30, 2025, utilizes firm fixed-price pricing and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,215.38 to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 5 mg, an anticoagulant medication commonly used in military and veteran healthcare settings. The contract was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, and represents a firm fixed-price, competitively awarded delivery order with no set-aside designation. Performance will be fulfilled at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $7,618.81 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The contract, which was competitively awarded without set-aside designation, has a completion date of July 25, 2025, one day after the award date. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. The firm fixed-price contract...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,065.95 for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This competitive award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, carries a firm fixed price structure with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order from...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,925.06 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, under a firm fixed-price contract type with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $9,070.54 to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing with an ultimate completion date of August 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies...
- The Defense Logistics Agency awarded a delivery order valued at $111,810.03 to AmerisourceBergen Drug Corp for 60-tablet supplies of Eliquis 5 mg tablets. This contract, executed on July 21, 2025, with an ultimate completion date of July 22, 2025, employs firm fixed pricing under a non-competitive, non-set-aside delivery order arrangement. The pharmaceutical product will be delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania, and the award represents a routine procurement...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRSL0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,484.04 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This non-set-aside contract was competitively awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract employs firm fixed pricing and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support, enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and Defense Health Agency operations worldwide. As a major pharmaceutical distributor, AmerisourceBergen regularly fulfills federal medical procurement requirements through competitively awarded delivery orders spanning multiple therapeutic domains, positioning the company as a critical vendor for the military's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 8/13/25 |